Overview of Dr. Clerkin
Dr. Kevin Clerkin is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 6 years. He is one of 696 doctors at New York-Presbyterian Hospital and one of 321 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Cardiology. He has more than 90 publications and over 500 citings.
Office
622 W 168th St
New York, NY 10032Fax+1 212-305-7439
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Advanced Heart Failure and Transplant Cardiology, 2018 - 2019
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Cardiovascular Disease, 2014 - 2018
- Columbia UniversityMSc, Biostatistics, 2015 - 2017
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2011 - 2014
- Albert Einstein College of MedicineClass of 2011
Certifications & Licensure
- CT State Medical License 2019 - 2025
- NJ State Medical License 2023 - 2025
- NY State Medical License 2013 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
- National Board of EchocardiographyComprehensive
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- 1105 citationsCOVID-19 and Cardiovascular Disease.Kevin J. Clerkin, Justin Fried, Jayant Raikhelkar, Gabriel Sayer, Jan M. Griffin
Circulation. 2020-05-19 - 15 citationsUnited network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis.Jan M. Griffin, Leonard Chiu, Kelly Axsom, Rachel Bijou, Kevin J. Clerkin
Clinical Transplantation. 2020-07-24 - 91 citationsDonor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantationKevin J. Clerkin, Maryjane Farr, Susan Restaino, Emmanuel Zorn, Farhana Latif
The Journal of Heart and Lung Transplantation. 2017-05-01
Journal Articles
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology
Authored Content
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
Press Mentions
- Study Affirms Higher CVD, Mortality Risks Among COVID-Positive PatientsOctober 26th, 2022
- Coronary and Cerebral Thrombosis in a Young Patient After Mild COVID-19 Illness: A Case ReportOctober 1st, 2020
- Cardiac Symptoms Can Be First Sign of COVID-19March 26th, 2020
- Join now to see all
Grant Support
- Identifying Novel Diagnostics and Mechanisms for Cardiac Allograft VasculopathyNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
Professional Memberships
- Fellow
- Fellow
- International Society for Heart and Lung TransplantationMember
External Links
- Columbia Profilehttps://www.columbiacardiology.org/profile/kevin-j-clerkin-md
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: